These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 21041085)

  • 21. Design, synthesis, and biological evaluation of prenylated chalcones as 5-LOX inhibitors.
    Reddy NP; Aparoy P; Reddy TC; Achari C; Sridhar PR; Reddanna P
    Bioorg Med Chem; 2010 Aug; 18(16):5807-15. PubMed ID: 20667741
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Chalcones, inhibitors for topoisomerase I and cathepsin B and L, as potential anti-cancer agents.
    Kim SH; Lee E; Baek KH; Kwon HB; Woo H; Lee ES; Kwon Y; Na Y
    Bioorg Med Chem Lett; 2013 Jun; 23(11):3320-4. PubMed ID: 23608763
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and topoisomerases inhibitory activity of heteroaromatic chalcones.
    Jeon KH; Yu HB; Kwak SY; Kwon Y; Na Y
    Bioorg Med Chem; 2016 Nov; 24(22):5921-5928. PubMed ID: 27707625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A New Series of Pyrrole-Based Chalcones: Synthesis and Evaluation of Antimicrobial Activity, Cytotoxicity, and Genotoxicity.
    Özdemir A; Altıntop MD; Sever B; Gençer HK; Kapkaç HA; Atlı Ö; Baysal M
    Molecules; 2017 Nov; 22(12):. PubMed ID: 29189730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
    Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
    Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
    Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
    Molecules; 2021 May; 26(10):. PubMed ID: 34064806
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis of chalcones with anticancer activities.
    Syam S; Abdelwahab SI; Al-Mamary MA; Mohan S
    Molecules; 2012 May; 17(6):6179-95. PubMed ID: 22634834
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chromenylchalcones showing cytotoxicity on human colon cancer cell lines and in silico docking with aurora kinases.
    Shin SY; Yoon H; Ahn S; Kim DW; Kim SH; Koh D; Lee YH; Lim Y
    Bioorg Med Chem; 2013 Jul; 21(14):4250-8. PubMed ID: 23719279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and anti breast cancer activity of biphenyl based chalcones.
    Sharma A; Chakravarti B; Gupt MP; Siddiqui JA; Konwar R; Tripathi RP
    Bioorg Med Chem; 2010 Jul; 18(13):4711-20. PubMed ID: 20605470
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthesis and biological evaluation of benzo[d][1,3]dioxol-5-yl chalcones as antiproliferating agents.
    Kamal A; Balakrishna M; Loka Reddy V; Riyaz S; Bagul C; Satyanarayana BM; Venkateswar Rao J
    Chem Biol Drug Des; 2015 Nov; 86(5):1267-84. PubMed ID: 26032623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological evaluation of glycosides containing triazene-chalcones.
    Lei Q; Zhang S; Liu M; Li J; Zhang X; Long Y
    Mol Divers; 2017 Nov; 21(4):957-966. PubMed ID: 28791568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New chalcone-sulfonamide hybrids exhibiting anticancer and antituberculosis activity.
    Castaño LF; Cuartas V; Bernal A; Insuasty A; Guzman J; Vidal O; Rubio V; Puerto G; Lukáč P; Vimberg V; Balíková-Novtoná G; Vannucci L; Janata J; Quiroga J; Abonia R; Nogueras M; Cobo J; Insuasty B
    Eur J Med Chem; 2019 Aug; 176():50-60. PubMed ID: 31096118
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis and selective cytotoxic activity of novel hybrid chalcones against prostate cancer cells.
    Nagaraju M; Gnana Deepthi E; Ashwini C; Vishnuvardhan MV; Lakshma Nayak V; Chandra R; Ramakrishna S; Gawali BB
    Bioorg Med Chem Lett; 2012 Jul; 22(13):4314-7. PubMed ID: 22668451
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis, biological evaluation and molecular docking studies of a new series of chalcones containing naphthalene moiety as anticancer agents.
    Wang G; Qiu J; Xiao X; Cao A; Zhou F
    Bioorg Chem; 2018 Feb; 76():249-257. PubMed ID: 29197743
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis and biological evaluation of a novel series of chalcones incorporated pyrazole moiety as anticancer and antimicrobial agents.
    Mohamed MF; Mohamed MS; Shouman SA; Fathi MM; Abdelhamid IA
    Appl Biochem Biotechnol; 2012 Nov; 168(5):1153-62. PubMed ID: 22948604
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Exploration of (hetero)aryl Derived Thienylchalcones for Antiviral and Anticancer Activities.
    Patil V; Patil SA; Patil R; Bugarin A; Beaman K; Patil SA
    Med Chem; 2019; 15(2):150-161. PubMed ID: 29792154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Design, Synthesis, and Biological Evaluation of Aromatic Amide-Substituted Benzimidazole-Derived Chalcones. The Effect of Upregulating
    Wu L; Yang Y; Wang Z; Wu X; Su F; Li M; Jing X; Han C
    Molecules; 2020 Mar; 25(5):. PubMed ID: 32150865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Synthesis, anticancer and antioxidant activities of 2,4,5-trimethoxy chalcones and analogues from asaronaldehyde: structure-activity relationship.
    Shenvi S; Kumar K; Hatti KS; Rijesh K; Diwakar L; Reddy GC
    Eur J Med Chem; 2013 Apr; 62():435-42. PubMed ID: 23395966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of Mannich bases of heterocyclic chalcone analogs as cytotoxic agents.
    Reddy MV; Su CR; Chiou WF; Liu YN; Chen RY; Bastow KF; Lee KH; Wu TS
    Bioorg Med Chem; 2008 Aug; 16(15):7358-70. PubMed ID: 18602831
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 5'-Chloro-2,2'-dihydroxychalcone and related flavanoids as treatments for prostate cancer.
    Saito Y; Mizokami A; Tsurimoto H; Izumi K; Goto M; Nakagawa-Goto K
    Eur J Med Chem; 2018 Sep; 157():1143-1152. PubMed ID: 30189396
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.